Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy for preventing cardiovascular disease in post-menopausal womenPotential role of tumor necrosis factor-α in downregulating sex hormone-binding globulinMethods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesisEstrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vesselsPotential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women.The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study.Circulating microparticles and endogenous estrogen in newly menopausal women.Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular diseaseImpact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.Effect of menopausal status on carotid intima-media thickness and presence of carotid plaque in Chinese women generation population.Genetic Variant in the CYP19A1 Gene Associated with Coronary Artery Disease.Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal womenProspective study of endogenous circulating estradiol and risk of stroke in older women.Vascular effects of estrogenic menopausal hormone therapy.Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study.Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.Androgens, Bilateral Oophorectomy, and Cardiovascular Disease Mortality in Postmenopausal Women With and Without Diabetes: The Study of Osteoporotic Fractures.Response to dr simes and dr snabes.Association of 10-Year Atherosclerotic Cardiovascular Disease Risk Score with Carotid Intima-Media Thickness and PlaqueEndogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition.Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention StudyPharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS).Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.Vascular actions of estrogens: functional implications.Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.Gender differences in the relationships among obesity, adiponectin and brachial artery distensibility in adolescents and young adults.Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal womenThe safety of postmenopausal testosterone therapy.Resveratrol Increases Hepatic SHBG Expression through Human Constitutive Androstane Receptor: a new Contribution to the French Paradox.Addition of Estradiol to Cross-Sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE-/- Mice.Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program.Oleic acid increases hepatic sex hormone binding globulin production in men.
P2860
Q24187326-D426D5EA-9E4C-49CA-9AD9-126AA4563541Q24197712-080D6359-615E-4828-8BD6-57BAFDCB2FD1Q24602925-D2802CBA-270D-46E9-BFDE-196FFEEF4578Q30868399-BC793084-AC33-46EF-B714-157C50DC51E0Q33781367-8D4F717B-221B-4618-AEAB-A2449A439350Q33786755-2137A0E6-9774-4860-B7A8-686F1CDC8CCBQ34007712-07EE0281-1A9C-42E3-AD78-1E6F85EFC200Q34113174-DFF3B87F-0F1F-4A1D-AAAC-834A11B86AEBQ34113211-24223ED8-F55B-4581-B72C-66CAF7C087A5Q34476755-6B267D78-706C-4368-8460-1C231B778D75Q34707823-A750E0A7-CAAC-4690-ADC8-76E98D39D351Q34712250-6D6087AD-2C76-4C90-9A46-7A6C863CB3CDQ35020549-CFBFFBA6-84CA-4DA1-A511-BA343ED074F0Q35230354-173C972A-8665-4CFB-B79D-EE8F9FD4DA61Q35242905-555628BF-EC32-4BC4-8306-344F70FB2EDCQ35526400-ED0D1BF7-A3F1-4158-955F-AF91A641D49FQ35583311-D0519061-E0B4-4440-AA5D-E2B9F5CFE9BDQ35597946-5E0E67E0-06D4-4030-B3D2-B35D6979031FQ36305233-B3D4A7B2-0747-45CC-9D4F-9765ACAEC749Q36311670-5117238B-7114-4DD7-8358-34FCDC34F2CAQ36328001-79176BB8-10E9-4492-A678-AE1CB2E63285Q36339001-DA43B142-BCF5-45DC-8981-3427C7BDE30DQ36339102-7ACB00E1-7CE8-4EA2-B545-3B170A0592ADQ36519047-4A17036C-E3DF-44D1-A59C-4DA04D7178A6Q36537470-9C697AD7-B8EF-41A3-8A4D-33AF69763494Q36589449-48A93B84-89A7-4093-9FD9-667DB36FDCFDQ36609707-CE342F21-7681-490D-B3C9-120B47F7F2DFQ36736281-1D9B10AD-4591-49F1-8A7A-352264FF9571Q36736491-BDD6CA52-D046-481E-AFBD-186E436D5A1CQ36753585-95983219-10A8-464B-A0E8-711B3C6A69C3Q37088243-982EB19C-196F-4D8A-9875-8612D8E57A6AQ37311487-FD386A27-5FC5-41E8-985F-116652A61D70Q37315515-A8B86591-D500-4C6F-BEC2-8D96A472C7E6Q37400638-D6EE8F6D-C5CC-44E6-ACC5-0983F59771B3Q37417429-AE04D3E8-5136-4494-9C93-B9ACBEAF8B62Q38007199-781984E0-C4C5-405F-8DD0-4EF8947BFBFAQ42363721-5DCBB3C0-FA99-49F7-84D1-32D30022AF29Q47563183-B22FF647-BF8D-45B6-A396-4A900786F839Q50002422-44696E11-1FAF-4CBB-B096-826CDBED6D4CQ50484573-987D99EF-9E57-498C-A77D-FD4F097220A5
P2860
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Relationship between serum lev ...... rosis in postmenopausal women.
@ast
Relationship between serum lev ...... rosis in postmenopausal women.
@en
type
label
Relationship between serum lev ...... rosis in postmenopausal women.
@ast
Relationship between serum lev ...... rosis in postmenopausal women.
@en
prefLabel
Relationship between serum lev ...... rosis in postmenopausal women.
@ast
Relationship between serum lev ...... rosis in postmenopausal women.
@en
P2093
P2860
P356
P1476
Relationship between serum lev ...... rosis in postmenopausal women.
@en
P2093
Frank Z Stanczyk
Howard N Hodis
Rogerio A Lobo
Roksana Karim
Wendy J Mack
P2860
P304
P356
10.1210/JC.2007-1738
P407
P577
2007-10-09T00:00:00Z